Filing Details
- Accession Number:
- 0001209191-23-002474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-06 19:04:13
- Reporting Period:
- 2023-01-04
- Accepted Time:
- 2023-01-06 19:04:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | Pharmaceutical Preparations (2834) | 510619477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1900012 | Anthony Molloy | C/O Pacira Biosciences, Inc. 5401 West Kennedy Boulevard, Suite 890 Tampa FL 33609 | Chief Lgl & Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-04 | 158 | $39.09 | 19,996 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-05 | 546 | $38.31 | 19,450 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- Includes 204 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
